SynAct Pharma to present at BioStock Investing in Life Science conference
Bitget2026/09/22 05:04- SynAct Pharma will present at BioStock Investing in Life Science 2026 on Sept. 22 in Stockholm.
- Management will attend LSX Congress USA 2026 in Boston on Sept. 22-24, including a panel session Sept. 22.
- Investor and partnering meetings planned at European MidCap Event 2026 on Sept. 30-Oct. 1 in Paris.
- Additional meetings set for Oct. 7-8 at Sachs Associates Biotech in Europe Forum in Basel.
- Bio Japan in Yokohama scheduled for Oct. 7-8, with management available for partner discussions.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
UBS CEO previews Q3 report: Wealth management business shows strong momentum, but performance growth will be lower than last year
UBS CEO Sergio Ermotti stated on Tuesday that the bank’s performance in the third quarter will show year-on-year growth, but the growth rate will be slower than in the same period in 2025.
Sail Mining names Willie Scott CFO, effective Oct. 1
Amazon Leo partners with Uztelecom unit UZ-SAT to expand satellite internet in Uzbekistan
Market Chatter: Braskem Creditors Seek $3 Billion Capital Injection From Controlling Holders
Crypto prices
More
